Clinical Context SGLT2 inhibitors have demonstrated cardiovascular benefits that aren’t fully explained by glucose lowering alone. Standard lipid panels (LDL-C,…
Browsing: PICO
Clinical Context Pregnancy in type 1 diabetes (T1D) requires meticulous glycemic management. Insulin requirements increase dramatically across gestation—typically 50-100% above…
Summary: In 126 pregnant women with type 1 diabetes, metformin (titrated to 1000 mg twice daily) as adjunct to standard…
Clinical Context Patients with diabetes undergoing percutaneous coronary intervention (PCI) with drug-eluting stents (DES) face a therapeutic dilemma: they have…
Clinical Context The transition from pediatric to adult diabetes care represents one of the most vulnerable periods for young people…
Summary: In adults with HFpEF (EF ≥50%), obesity (BMI ≥30 kg/m²), stratified by presence or absence of type 2 diabetes…
Clinical Context Heart failure with preserved ejection fraction (HFpEF) represents approximately half of all heart failure cases and has proven…
Clinical Context Type 2 diabetes requires sustained self-management: daily medication adherence, dietary modification, physical activity, and glucose monitoring. Many patients…
Clinical Context SGLT2 inhibitors have transformed type 2 diabetes management, offering glycemic control alongside weight loss, blood pressure reduction, and…
Clinical Context SGLT2 inhibitors have demonstrated remarkable cardiovascular benefits in large outcome trials, reducing heart failure hospitalizations and cardiovascular death…